Weight loss · Aging & longevity

Semaglutide, simplified.

Also called Ozempic, Wegovy, Rybelsus

Approved Rx

A lab-made copy of a gut hormone called GLP-1 that tells your brain you are full. It is the active ingredient in Ozempic and Wegovy.

Size
31 amino acids
How it is taken
Weekly injection or daily tablet
Status
FDA-approved prescription
Available sizes
Vials: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg

What is it?

After you eat, your gut releases a hormone called GLP-1. It tells your brain you have had enough and slows how fast your stomach empties. Semaglutide acts like GLP-1 but lasts about a week instead of a few minutes.

Got a vial? See how it mixes

Tap your vial size to watch how it is mixed and see exactly what each mark on the syringe holds.

Official prescribing information

Wegovy and Ozempic are FDA-approved. The official label shows how it was dosed in the trials that led to approval, along with warnings and who should not use it.

Doses on the label are for the approved product under a prescriber’s care. Talk with your doctor before starting anything.

Read the FDA label ↗

What studies show

What we don’t know yet

Side effects and cautions

Is it legal?

Dosage & schedule evidence

How to read published schedules

FDA-approved products exist for specific indications, and schedules vary by product, indication, and formulation. Follow the current official prescribing information and your clinician's instructions.

MeasurementMeaning
1 mg1,000 mcg (mass)
100 U-100 units1 mL (volume, not dose)

For source context, see third-party published protocols ↗. North Star does not validate these schedules.

Consult your doctor before considering any peptide for personal use. Educational only, not administration guidance.

Common questions

What is Semaglutide?

A lab-made copy of a gut hormone called GLP-1 that tells your brain you are full. It is the active ingredient in Ozempic and Wegovy. After you eat, your gut releases a hormone called GLP-1. It tells your brain you have had enough and slows how fast your stomach empties. Semaglutide acts like GLP-1 but lasts about a week instead of a few minutes.

What does the research say about Semaglutide?

In a large 68-week trial, adults with obesity lost about 15% of their body weight on average, compared with about 2% on placebo. In a trial of 17,000+ people with heart disease and excess weight, it lowered the risk of heart attack, stroke and heart-related death by about 20%. It lowers blood sugar in type 2 diabetes, which is what it was first approved for.

Is Semaglutide FDA approved?

FDA-approved. Available only with a prescription.

What are the side effects of Semaglutide?

Nausea, vomiting, diarrhea and constipation are common, especially early on. Rare risks include pancreatitis and gallbladder problems. Not for people with a personal or family history of medullary thyroid cancer or MEN2.

Comes in these blends

Related peptides

Not sure where to start?

Answer 8 quick questions and see which peptides the research points to for your goal.

Find my stack

Already know you want Semaglutide? Ask Mark about it →

This page explains published research in plain language. It is not medical advice, a diagnosis, or a recommendation to take anything, and it does not give dosing. Most peptides here are not FDA-approved, and products sold online vary widely in purity. Rules around peptides are changing, so check the current status and talk with a licensed clinician before starting anything. Last reviewed 2026-10-19.